Skip to main content

Table 4 Effects of TRF on the concentrations of tocols in canine plasma and platelets1

From: Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries

Treatments Total tocopherols (T)2 Total tocotrienols (T3)3 Total T + T3
TRF4 Concentrations in μg/mL (ppm)  
Plasma (Pre-dose)    
Total Tocols5 19.72 ± 1.29 a (92) 6 1.65 ± 0.03 a (8) 21.37 ± 1.13 a (100) 6
Plasma (Post-dose)    
Total Tocols 67.38 ± 2.25 b (89) 8.56 ± 0.04 b (11) 75.94 ± 2.21 b (100)
Platelets (Pre-dose)    
Total Tocols 7.85 ± 0.62 a (67) 3.85 ± 0.23 a (33) 11.70 ± 0.48 a (100)
Platelets (Post-dose)    
Total Tocols 31.44 ± 1.84 b (89) 3.84 ± 0.12 a (11) 35.28 ± 1.70 b (100)
  1. 1Data expressed as means ± SD, n = 3, 3, and 4 respectively, per treatment.
  2. 2Total tocopherols = Mixture of α-tocopherol + β-tocopherol + γ-tocopherol + δ-tocopherol.
  3. 3Total tocotrienols = Mixture of α-tocotrienol + β-tocotrienol + γ-tocotrienol + δ-tocotrienol
  4. 4TRF = Tocotrienol Rich Fraction (Mixture of 15% α-tocotrienol + 60% γ-tocotrienol + 25% δ-tocotrienol)
  5. from palm oil (Purified at AMR, Madison, WI).
  6. 5Tocols = Mixture of α-, β-, γ-, and δ-tocopherols (T) + α-, β-, γ-, and δ-tocotrienols (T3).
  7. 6Percentages of control values are in parentheses.
  8. a-bValues in columns with a different superscript letter are significantly different at P < 0.05.